Full name
A&DE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
46.46 - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
70.21.Z - Head office activities and management consultancy
72.11.Z - Scientific research and development activities
96.09.Z - Individual service activities
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Profit (loss) on sale | 0,4 | 0,2 | -46,1 |
Gross profit (loss) | 0,3 | 0,2 | -43 |
EBITDA | 0,3 | 0,2 | -40 |
Short time liabilities | 0 | 0 | -55,5 |
Other operating costs | 0 | 0 | -98,1 |
Equity capital | 0,4 | 0,5 | 50,6 |
Operating profit (EBIT) | 0,3 | 0,2 | -41,3 |
Assets | 0,5 | 0,7 | 24,5 |
Net profit (loss) | 0,3 | 0,2 | -43 |
Cash | 0,1 | 0,1 | -38,6 |
Net income from sale | 1,6 | 1,6 | -5,2 |
Liabilities and provisions for liabilities | 0,2 | 0,1 | -30,1 |
Working assets | 0,5 | 0,6 | 19,9 |
Other income costs | 0 | 0 | 52,1 |
Depreciation | 0 | 0 | -∞ |
% | % | p.p. | |
Profitability of capital | 88,7 | 33,6 | -55,1 |
Equity capital to total assets | 67,6 | 81,8 | 14,2 |
Gross profit margin | 21 | 12,6 | -8,4 |
EBITDA Margin | 21,1 | 13,4 | -7,7 |
Days | Days | Days | |
Short term commitment turnover cycle | 9 | 4 | -5 |
Current financial liquidity indicator | 12.551878929138184 | 33.82677459716797 | 21,2 |
Net dept to EBITDA | 0.0108192665502429 | 0.11418068408966064 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane